Cargando…
Favipiravir: Hyperuricaemia and lack of efficacy following off-label use: 2 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023666/ http://dx.doi.org/10.1007/s40278-022-13744-z |
Ejemplares similares
-
Favipiravir/voriconazole: Hyperuricaemia, transaminitis and off-label use: case report
Publicado: (2021) -
Favipiravir: Hyperuricaemia and acute gouty arthritis following off-label use: case report
Publicado: (2020) -
Favipiravir: Hyperuricaemia: case report
Publicado: (2021) -
Favipiravir: Lack of efficacy following off-label treatment: case report
Publicado: (2021) -
Favipiravir/methylprednisolone: Off-label use and lack of efficacy: case report
Publicado: (2022)